KELLY RUSSIN: Open Payments
NPI 1780745554 · UNION CITY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$972 in 61 payments from 13 companies in 2025. Trend: 2023 $1,261 · 2024 $981 · 2025 $972
Food & beverage: $972
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $265 |
| Novo Nordisk Inc | 13 | $188 |
| AstraZeneca Pharmaceuticals LP | 5 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $87 |
| Lundbeck LLC | 3 | $77 |
| Lilly USA, LLC | 2 | $62 |
| Amgen Inc. | 3 | $43 |
| Bausch Health US, LLC | 2 | $40 |
| Organon LLC | 2 | $38 |
| PFIZER INC. | 1 | $23 |
Products named: QULIPTA, JARDIANCE, REXULTI, Ozempic, VRAYLAR, Rybelsus, OTEZLA, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
